CIMB downgraded ResMed (NYSE: RMD) from Outperform to Hold.

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Downgrades

Morgan Stanley Downgrades ResMed (RMD) to EqualweightJanuary 28, 2014 6:50 AM William Blair Downgrades ResMed (RMD) to Market PerformJanuary 24, 2014 8:29 AM ResMed, Inc. (RMD) Misses Q2 EPS by 3cJanuary 23, 2014 4:19 PM